| 000 | 01047 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250512013154.0 | ||
| 264 | 0 | _c19891215 | |
| 008 | 198912s 0 0 eng d | ||
| 022 | _a0952-7915 | ||
| 024 | 7 |
_a10.1016/0952-7915(89)90069-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLotzová, E | |
| 245 | 0 | 0 |
_aAnalysis of effector mechanisms in cancer. _h[electronic resource] |
| 260 |
_bCurrent opinion in immunology _cJun 1989 |
||
| 300 |
_a904-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-2 _xpharmacology |
| 650 | 0 | 4 |
_aKiller Cells, Lymphokine-Activated _ximmunology |
| 650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
| 650 | 0 | 4 |
_aLymphocytes _ximmunology |
| 650 | 0 | 4 |
_aNeoplasms _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 773 | 0 |
_tCurrent opinion in immunology _gvol. 1 _gno. 5 _gp. 904-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0952-7915(89)90069-1 _zAvailable from publisher's website |
| 999 |
_c2685619 _d2685619 |
||